Soluble thrombomodulin and endothelial dysfunction in early atherosclerosis [8]

Lancet

Volumn 354, Issue 9190, 1999, Pages 1647-

  John, S ^a   Drobnik, W ^a   Lackner, K ^a   Schmider, R E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL MARKER; CELL SURFACE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; THROMBOMODULIN;

ARM BLOOD FLOW; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD LEVEL; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; HYPERCHOLESTEROLEMIA; INTRAARTERIAL DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SOLUBILITY; STATISTICAL ANALYSIS; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0033530460     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77135-X     Document Type: Letter

References (4)

1. V Salomaa C Matei N Aleksic Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-control study Lancet 353 1999 1729 1734
2. S John M Schlaich M Langenfeld Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled double-blind study Circulation 98 1998 211 216
3. PJ Chowienczyk GF Watts JR Cockcroft JM Ritter Impaired endothelium-dependent vasodilation in forearm resistance vessels in hypercholesterolaemia Lancet 340 1992 1430 1432
4. PP Nawroth HU Häring Thrombomodulin and coronary heart disease Lancet 353 1999 1722 1723